Drug:
Reaction: PRODUCT USE ISSUE
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555753 |
US |
66 | 2 |
Urinary tract infection, Product use issue, |
||||
TIRZEPATIDE, |
||||
| 2 | 26555759 |
US |
1 | |
Gastrointestinal disorder, Product use issue, |
||||
TIRZEPATIDE, |
||||
| 3 | 26555961 |
US |
40 | 2 |
Extra dose administered, Product use issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 4 | 26556004 |
CN |
||
Accidental overdose, Product use issue, |
||||
DARIDOREXANT, |
||||
| 5 | 26556485 |
JP |
5 | 1 |
Cytokine release syndrome, Immune-mediated hepatic disorder, Product use issue, |
||||
PEMBROLIZUMAB, LENVATINIB, |
||||
| 6 | 26556774 |
KR |
67 | 1 |
Drug reaction with eosinophilia and systemic symptoms, Product use issue, |
||||
LAMOTRIGINE, |
||||
| 7 | 26556870 |
US |
||
Incorrect dose administered, Headache, Product use issue, |
||||
ACALABRUTINIB, |
||||
| 8 | 26557087 |
EU |
17 | 2 |
Antipsychotic drug level increased, Product use issue, Product administered to patient of inappropriate age, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE, |
||||
| 9 | 26557286 |
73 | ||
Blood pressure increased, Inappropriate schedule of product administration, Product use issue, Therapy interrupted, |
||||
LACOSAMIDE, |
||||
| 10 | 26557358 |
US |
65 | 2 |
Hospitalisation, Product use issue, |
||||
| 11 | 26557576 |
US |
72 | 2 |
Product use issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 12 | 26557707 |
US |
||
Dyspnoea, Product use issue, Device delivery system issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 13 | 26557754 |
EU |
1 | |
Follicular lymphoma, Neutropenia, Sinus tachycardia, Product use issue, |
||||
CLOZAPINE, BISOPROLOL FUMARATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 14 | 26557952 |
US |
51 | |
Product use issue, No adverse event, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 15 | 26558280 |
2 | ||
Inappropriate schedule of product administration, Product use issue, |
||||
| 16 | 26558321 |
US |
71 | 2 |
Drug ineffective, Product use issue, |
||||
NICOTINE, |
||||
| 17 | 26558712 |
US |
35 | |
Headache, Product use issue, Influenza, |
||||
ISOTRETINOIN, |
||||
| 18 | 26558744 |
US |
69 | 2 |
Product use issue, Oesophageal disorder, Oesophagitis, Drug ineffective, Crying, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 19 | 26558761 |
US |
24 | |
Product use issue, |
||||
ISOTRETINOIN, |
||||
| 20 | 26558842 |
US |
74 | 2 |
Parkinson^s disease, Feeding disorder, Weight decreased, Product use issue, Drug dose titration not performed, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 21 | 26558855 |
US |
||
Product use issue, |
||||
ISOTRETINOIN, |
||||
| 22 | 26558963 |
US |
6 | 1 |
Product use issue, Wrong technique in product usage process, |
||||
SORAFENIB, SORAFENIB, CISPLATIN, DEXRAZOXANE FOR INJECTION, DEXRAZOXANE, DOXORUBICIN, |
||||
| 23 | 26558988 |
EU |
15 | |
Poisoning, Intentional overdose, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 24 | 26559145 |
US |
2 | |
Device occlusion, Irritability, Refusal of treatment by patient, Prescription drug used without a prescription, Product use issue, Expulsion of medication, |
||||
TOVORAFENIB, TOVORAFENIB, |
||||
| 25 | 26559241 |
BR |
2 | |
Seizure, Product packaging quantity issue, Drug ineffective, Product use issue, |
||||
DIVALPROEX SODIUM, DIVALPROEX SODIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 26 | 26559425 |
EU |
65 | 2 |
Liver disorder, Biliary tract disorder, Product use issue, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 27 | 26559433 |
EU |
13 | 2 |
Product use issue, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 28 | 26559435 |
US |
51 | 2 |
Extra dose administered, Product use issue, |
||||
TIRZEPATIDE, |
||||
| 29 | 26559483 |
US |
69 | 1 |
Grimacing, Anxiety, Drug titration error, Product use issue, Contraindicated product administered, Fatigue, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, VALBENAZINE, |
||||
| 30 | 26559589 |
US |
68 | 2 |
Pneumonia bacterial, Acute respiratory failure, Acute kidney injury, Hyperkalaemia, Hypoalbuminaemia, Haemorrhage, Pulseless electrical activity, Septic shock, Cardiogenic shock, Arrhythmia, Right ventricular failure, Cardiac failure acute, Influenza, Interstitial lung disease, Pulmonary hypertension, Death, Product use issue, Incorrect dose administered, Acidosis, Hyperglycaemia, Weight decreased, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, DULOXETINE HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CYANOCOBALAMIN, PANTOPRAZOLE SODIUM, INSULIN ASPART, MACITENTAN, EPOPROSTENOL, ATORVASTATIN CALCIUM, EZETIMIBE, LATANOPROST, PREDNISONE, SPIRONOLACTONE, OXYGEN, 0XYGEN, PRAMIPEXOLE DIHYDROCHLORIDE, DIGOXIN, MIDODRINE HYDROCHLORIDE, DAPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TORSEMIDE, BIMATOPROST, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 31 | 26559695 |
US |
82 | 2 |
Product use issue, Malaise, |
||||
MAVACAMTEN, |
||||
| 32 | 26559699 |
EU |
15 | |
Blood test abnormal, Poisoning, Liver function test abnormal, Aspartate aminotransferase increased, Alanine aminotransferase increased, Product use issue, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 33 | 26559945 |
US |
1 | |
Product dose omission issue, Product use issue, No adverse event, |
||||
SITAGLIPTIN PHOSPHATE, |
||||
| 34 | 26560785 |
|||
Product use issue, |
||||
POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, |
||||
| 35 | 26560842 |
US |
72 | 1 |
Ammonia increased, Hepatic cirrhosis, Condition aggravated, Hospitalisation, Confusional state, Therapy interrupted, Product use issue, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 36 | 26560864 |
JP |
8 | 1 |
Orthopaedic procedure, Product use issue, |
||||
ORAL SEMAGLUTIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DAPAGLIFLOZIN, GLIMEPIRIDE, PIOGLITAZONE, ACARBOSE, |
||||
| 37 | 26560943 |
EG |
69 | 2 |
Critical illness, Intentional product misuse, Inappropriate schedule of product administration, Product use issue, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 38 | 26561011 |
EU |
15 | |
Poisoning, Product use issue, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 39 | 26561325 |
EU |
56 | 2 |
Angiopathy, Gastrointestinal sounds abnormal, Increased appetite, Visual impairment, Eructation, Flatulence, Diarrhoea, Product use issue, Drug titration error, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, CANDESARTAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BISOPROLOL FUMARATE, AMLODIPINE BESYLATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 40 | 26561435 |
2 | ||
Abdominal pain upper, Product use issue, |
||||
TENAPANOR HYDROCHLORIDE, |
||||
| 41 | 26561565 |
US |
33 | |
Pneumonia, Product use issue, |
||||
| 42 | 26561576 |
US |
2 | |
Chronic kidney disease, Product use issue, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 43 | 26561620 |
CA |
72 | 2 |
Atrial fibrillation, Gastrooesophageal reflux disease, Back pain, Weight decreased, Nasal congestion, Tachycardia, Polyp, Asthenia, Hypersensitivity, Product use issue, Rectal haemorrhage, Asthma, Haemorrhoids, Skin lesion, |
||||
FLUTICASONE PROPIONATE, IRON, FLUTICASONE PROPIONATE, CANDESARTAN, CANDESARTAN CILEXETIL, CICLESONIDE, DULOXETINE HYDROCHLORIDE, TOLTERODINE TARTRATE, GABAPENTIN, GABAPENTIN, LANSOPRAZOLE, ATORVASTATIN CALCIUM, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CICLESONIDE, ROPINIROLE, ROPINIROLE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, TEMAZEPAM, ALBUTEROL SULFATE, MEPOLIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 44 | 26569786 |
49 | 1 | |
Gastrointestinal disorder, Treatment noncompliance, Product use issue, |
||||
RIFAXIMIN, AMLODIPINE BESYLATE, CARVEDILOL, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DOXAZOSIN MESYLATE, SITAGLIPTIN, TELMISARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, TORSEMIDE, |
||||
| 45 | 26570211 |
1 | ||
Infection, Rash, Quality of life decreased, Product use issue, Pulmonary vasculitis, Condition aggravated, |
||||
MEPOLIZUMAB, |
||||
| 46 | 26550488 |
CA |
||
Maternal exposure timing unspecified, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Infusion related reaction, Intentional product misuse, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, Immunodeficiency, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DOLUTEGRAVIR SODIUM, |
||||
| 47 | 26550683 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, C-reactive protein, C-reactive protein abnormal, Chest pain, Decreased appetite, Deep vein thrombosis postoperative, Drug hypersensitivity, Fatigue, Gait inability, Hypersensitivity, Hypertension, Hypertransaminasaemia, Hypoaesthesia, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Leukopenia, Live birth, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lupus vulgaris, Malaise, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Osteoarthritis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pregnancy, Pruritus, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid factor positive, Sciatica, Sinusitis, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Ulcer haemorrhage, Maternal exposure during pregnancy, Prescribed overdose, Product use in unapproved indication, Off label use, Product use issue, Therapy non-responder, Treatment failure, Therapeutic product effect decreased, Drug ineffective, Therapeutic response decreased, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, PREGABALIN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, CERTOLIZUMAB PEGOL, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, MAGNESIUM, MAGNESIUM, ERGOCALCIFEROL, RAMIPRIL, SULFASALAZINE, PIROXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LORAZEPAM, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LANSOPRAZOLE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, CYANOCOBALAMIN, FISH OIL, CAFFEINE, LORAZEPAM, |
||||
| 48 | 26550736 |
US |
79 | 2 |
Product use issue, Product dose omission issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 49 | 26550804 |
US |
2 | |
Ocular hyperaemia, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Inappropriate schedule of product administration, Circumstance or information capable of leading to medication error, Product use issue, |
||||
PERFLUOROHEXYLOCTANE, |
||||
| 50 | 26550933 |
US |
24 | 1 |
Injection site swelling, Injection site pain, Product use issue, |
||||
RISPERIDONE, RISPERIDONE, RISPERIDONE, |
||||
| 51 | 26550959 |
US |
74 | 1 |
Hip arthroplasty, Incorrect dose administered, Product use issue, |
||||
RELUGOLIX, |
||||
| 52 | 26551054 |
AU |
20 | 2 |
Akathisia, Oculogyric crisis, Drug ineffective, Maternal exposure during pregnancy, Product use issue, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PROCHLORPERAZINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 53 | 26551203 |
US |
49 | 2 |
Product use issue, |
||||
TREPROSTINIL, |
||||
| 54 | 26551260 |
US |
2 | |
Product use issue, Intentional product misuse, |
||||
| 55 | 26551339 |
US |
2 | |
Product use issue, Intentional product misuse, |
||||
| 56 | 26551390 |
CN |
57 | 1 |
Upper gastrointestinal haemorrhage, Palpitations, Asthenia, Hyperhidrosis, Product use issue, Haematemesis, Dizziness, Melaena, Frequent bowel movements, Vomiting, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 57 | 26551480 |
CN |
57 | 2 |
Liver injury, Product use issue, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 58 | 26551497 |
US |
1 | |
Product use issue, Product physical consistency issue, Poor quality product administered, |
||||
| 59 | 26551581 |
US |
2 | |
Product use issue, Intentional product misuse, |
||||
| 60 | 26551598 |
US |
60 | 1 |
No adverse event, Product use issue, |
||||
DEXLANSOPRAZOLE, |
||||
| 61 | 26551667 |
US |
||
Hepatic pain, Product use issue, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 62 | 26551746 |
EU |
75 | |
Intestinal perforation, Drug ineffective, Product use issue, |
||||
RITUXIMAB, POLATUZUMAB VEDOTIN, GLOFITAMAB, BENDAMUSTINE HCL, |
||||
| 63 | 26551755 |
53 | 1 | |
Dopamine agonist withdrawal syndrome, Intentional overdose, Product use issue, Off label use, |
||||
GABAPENTIN, PRAMIPEXOLE, DULOXETINE HYDROCHLORIDE, DULOXETINE, FUROSEMIDE, |
||||
| 64 | 26551761 |
US |
2 | |
Therapeutic product effect incomplete, Product use issue, |
||||
DEUTETRABENAZINE, |
||||
| 65 | 26552207 |
AR |
80 | 1 |
Product use issue, Feeling of body temperature change, Hot flush, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 66 | 26552758 |
CA |
58 | 2 |
Asthma, Back pain, Bursitis, Coeliac disease, Constipation, Contraindicated product administered, Decreased immune responsiveness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Erythema, Exposure during pregnancy, Fatigue, Fluid retention, Foetal death, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infusion related reaction, Intentional product misuse, Joint swelling, Pain, Prescribed overdose, Product use issue, Psoriasis, Pyrexia, Rash, Rash erythematous, Rheumatoid arthritis, Temperature regulation disorder, Thrombocytopenia, Treatment failure, Upper respiratory tract infection, Infection, Hyponatraemia, Leukopenia, Nausea, Retching, Overdose, Off label use, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, OXYCODONE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, QUETIAPINE FUMARATE, QUETIAPINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FLUCONAZOLE, FLUCONAZOLE, FLUCONAZOLE, FLUCONAZOLE, FUROSEMIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, MONTELUKAST, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ABACAVIR SULFATE, ABACAVIR SULFATE, ABACAVIR SULFATE, ABACAVIR SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, BUPROPION, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, ETANERCEPT, GABAPENTIN, ADALIMUMAB, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL SULFATE, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, TEMAZEPAM, TEMAZEPAM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, VITAMIN C, VITAMIN C, VITAMIN C, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, ABACAVIR SULFATE, ABACAVIR, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ALBUTEROL SULFATE, PROGESTERONE, CYCLOBENZAPRINE, LAMIVUDINE, LAMIVUDINE ORAL, MORPHINE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, PROGESTERONE, PROGESTERONE, RANITIDINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TEMAZEPAM, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, SENNA LEAF, SENNA, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALBUTEROL SULFATE, ALBUTEROL, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, VITAMIN C, PREGABALIN, PREGABALIN, |
||||
| 67 | 26553227 |
US |
59 | 1 |
Weight increased, Product use issue, |
||||
DEGARELIX, GALLIUM GA-68 GOZETOTIDE, ABIRATERONE ACETATE, ABIRATERONE, APIXABAN, PREDNISONE, MELATONIN, |
||||
| 68 | 26553244 |
US |
1 | |
Product use issue, |
||||
DEGARELIX, |
||||
| 69 | 26553449 |
US |
40 | 2 |
Brain injury, Product use issue, Anxiety, |
||||
VORTIOXETINE, |
||||
| 70 | 26553553 |
EU |
20 | 2 |
Neutropenia, Product use in unapproved indication, Product use issue, Off label use, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, OXAZEPAM, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, ARIPIPRAZOLE, TOPIRAMATE, TOPIRAMATE SPINKLE, MELATONIN, SCOPOLAMINE, |
||||
| 71 | 26553734 |
EU |
81 | 2 |
Cardiac failure, Multiple fractures, Hip fracture, Fall, Rib fracture, Hyponatraemia, Product use issue, |
||||
POMALIDOMIDE, SELINEXOR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 72 | 26553742 |
EU |
4 | 1 |
Drug ineffective, Product use issue, |
||||
EPINEPHRINE, TRANEXAMIC ACID, OXYMETAZOLINE, |
||||
| 73 | 26553964 |
|||
Dementia Alzheimer^s type, Pneumonia, Partial seizures, Cough, Product use issue, Product use in unapproved indication, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, BRIVARACETAM, BRIVARACETAM, LACOSAMIDE, LACOSAMIDE, |
||||
| 74 | 26554012 |
US |
80 | 1 |
Product use issue, |
||||
ENSIFENTRINE, |
||||
| 75 | 26554077 |
US |
79 | 1 |
Product use issue, Product dose omission issue, |
||||
ENSIFENTRINE, ENSIFENTRINE, |
||||
| 76 | 26554081 |
US |
2 | |
Product use issue, Product distribution issue, |
||||
ENSIFENTRINE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 77 | 26554099 |
US |
2 | |
Oral pain, Lip pain, Hypoaesthesia oral, Oral discomfort, Oral hyperaesthesia, Tongue discomfort, Tongue discolouration, Glossodynia, Product use issue, Inappropriate schedule of product administration, Drug ineffective, Therapy interrupted, |
||||
ENSIFENTRINE, ENSIFENTRINE, ENSIFENTRINE, TIOTROPIUM BROMIDE AND OLODATEROL, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 78 | 26554471 |
EU |
16 | |
Poisoning, Product use issue, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 79 | 26564232 |
1 | ||
Renal failure, Cystitis, Psoriatic arthropathy, Product use issue, Product dose omission issue, Pain, |
||||
TOFACITINIB, |
||||
| 80 | 26564617 |
1 | ||
Renal failure, Cystitis, Product use issue, |
||||
TAFAMIDIS, PRIMIDONE, VITAMIN C, |
||||
| 81 | 26548950 |
US |
56 | 2 |
Incorrect dose administered, Product use issue, |
||||
TIRZEPATIDE, |
||||
| 82 | 26549012 |
EU |
||
Hepatotoxicity, Diabetes mellitus, Product use issue, |
||||
RITUXIMAB, POLATUZUMAB VEDOTIN, DOXORUBICIN, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 83 | 26549945 |
US |
70 | 2 |
Product use issue, Extra dose administered, Laryngitis, Throat irritation, Fibromyalgia, Illness, Vomiting, Memory impairment, |
||||
INSULIN HUMAN, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 84 | 26547056 |
US |
||
Product use issue, Product adhesion issue, |
||||
ESTRADIOL, |
||||
| 85 | 26547093 |
US |
74 | 2 |
Rhabdomyolysis, Fall, Product use issue, Dyspnoea, Cardiac disorder, |
||||
TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE INHALATION SPRAY, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 86 | 26547309 |
US |
||
Product use issue, |
||||
UPADACITINIB, |
||||
| 87 | 26547424 |
US |
2 | |
Product adhesion issue, Product use issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 88 | 26547647 |
US |
||
Product use issue, |
||||
VENETOCLAX, |
||||
| 89 | 26547811 |
US |
70 | 2 |
Blood pressure abnormal, Product use issue, |
||||
VIBEGRON, |
||||
| 90 | 26547834 |
US |
62 | 2 |
Eczema, Product dose omission in error, Product use issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 91 | 26548212 |
US |
2 | |
Product use issue, Product adhesion issue, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 92 | 26548718 |
US |
3 | 1 |
Product use issue, |
||||
DUPILUMAB, |
||||
| 93 | 26548811 |
US |
76 | 1 |
Blood glucose increased, Product use issue, |
||||
RELUGOLIX, |
||||
| 94 | 26548817 |
US |
88 | 1 |
Fatigue, Product use issue, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 95 | 26542088 |
US |
59 | |
Product use issue, Palpitations, Oedema peripheral, |
||||
POMALIDOMIDE, POMALIDOMIDE, |
||||
| 96 | 26542376 |
US |
21 | 1 |
Product use issue, Off label use, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 97 | 26542409 |
US |
16 | |
Product use issue, Rash, |
||||
ISOTRETINOIN, |
||||
| 98 | 26542416 |
US |
||
Product use issue, |
||||
NICOTINE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, |
||||
| 99 | 26542417 |
US |
2 | |
Overdose, Product use issue, Product adhesion issue, |
||||
NICOTINE, NICOTINE TRANSDERMAL SYSTEM, |
||||
| 100 | 26542952 |
US |
2 | |
Accidental exposure to product, Product use issue, Product dose omission issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28